ArticleCancers2021

Centralised RECIST Assessment and Clinical Outcomes with Lenvatinib Monotherapy in Recurrent and Metastatic Adenoid Cystic Carcinoma.

Laura Feeney et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.